Product Pathways - Growth Factors/Cytokines
Mouse His6Interleukin-6 (mHis6IL-6) #8857
|8857SC||10 µg ( With Carrier )||￥2,580.00 现货查询||购买询价|
|8857SF||10 µg ( Carrier Free )||￥2,580.00 现货查询||购买询价|
|8857||carrier free & custom formulation / quantity||email request|
Species cross-reactivity is determined by western blot.
Source / Purification
Recombinant mouse His6IL-6 (mHis6IL-6) Phe25-Thr211 (Accession #NP_112445) was expressed in human 293 cells at Cell Signaling Technology.
CST公司利用重组的鼠His6IL-6 (mHis6IL-6) Phe25-Thr211 (Accession #NP_112445)在人的293细胞中表达。
Recombinant N-terminally His6-tagged mIL-6 has a calculated MW of 24,311. DTT-reduced and non-reduced protein migrate as 31-36 kDa polypeptides. Lower mobility and heterogeneity in SDS-PAGE are due to glycosylation. The expected amino terminus of recombinant mHis6IL-6 was verified by amino acid sequencing.
重组的mIL-6蛋白在N-末端有His6标签，其分子量据推算为24,311Da。DTT-还原 和 未还原的蛋白迁移时是作为一个31-36kDa 的多肽而转移。其在SDS-PAGE胶中的双重迁移性质与低迁移速率是由于糖基化。重组mHis6IL-6蛋白的N-末端序列通过测序得到。
>98% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant mHis6IL-6. All lots are greater than 98% pure.
6 μg 还原 (+) 和 非还原的(-) mHis6IL-6通过SDS-PAGE检测，纯度大于98%，所有批次的纯度均高于98%。
The bioactivity of recombinant mIL-6 was determined in a B9 cell proliferation assay. The ED50 of each lot is between 0.5 and 5 pg/ml.重组蛋白mIL-6的生物活性是通过B9细胞增殖实验确定的。每个lot的ED50在0.5-5 pg/ml之间。
The purity of recombinant mHis6IL-6 was determined by SDS-PAGE of 6 µg reduced (+) and non-reduced (-) recombinant mHis6IL-6 and staining overnight with Coomassie Blue.重组蛋白mHis6IL-6的纯度用6 µg 降解(+)和未降解(-)的蛋白走SDS-PAGE 胶来观察。考马斯亮蓝染色过夜。
The proliferation of B9 cells treated with increasing concentrations of mHis6IL-6 was assessed. After 48 hr treatment with mHis6IL-6, cells were incubated with a tetrazolium salt and the OD450 - OD650 was determined.用逐渐递增浓度的mHis6IL-6处理B9细胞的细胞增殖实验。在mHis6IL-6中处理48小时，细胞在四唑盐中孵育并读取OD450 - OD650 的数值。
Western blot analysis of extracts from B9 cells, untreated or treated with increasing concentrations of mHis6IL-6 for 10 min, using Phospho-Stat3 (Tyr705) (D3A7) XP® Rabbit mAb #9145 (upper) and Stat3 (79D7) Rabbit mAb #4904 (lower).Western免疫印迹。用Phospho-Stat3 (Tyr705) (D3A7) XP® Rabbit mAb #9145(上图)和Stat3 (79D7) Rabbit mAb #4904(下图)研究未经处理和用递增浓度mHis6IL-6处理10分钟的B9细胞的细胞提取液。
The ability of mHis6IL-6 to induce phosphorylation of Stat3 was assessed. B9 cells were treated with increasing concentrations of mHis6IL-6 for 10 min. Cells were lysed, and phospho-Stat3 was quantified using PathScan® Phospho-Stat3 (Tyr705) Sandwich ELISA Kit #7300. OD450 is shown.研究mHis6IL-6诱导Stat3磷酸化能力的实验。用递增浓度mHis6IL-6处理B9细胞10分钟，裂解细胞，磷酸化Stat3蛋白用PathScan® Phospho-Stat3 (Tyr705) Sandwich ELISA Kit #7300定量。图中所示为OD450的数值。
Less than 0.01 ng endotoxin/1 μg mHis6IL-6.
内毒素含量:<0.01 ng/1 μg mHis6IL-6。
With carrier: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2 containing 20 μg BSA per 1 μg mHis6IL-6. Carrier free: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2.
有载体: 每微克mHis6IL-6蛋白溶解在包含 20 μg BSA的PBS（pH 7.2）溶液中，并通过 0.22 μm 滤膜冻干。
无载体：每微克mHis6IL-6蛋白溶解在PBS（pH 7.2）溶液中，并通过 0.22 μm 滤膜冻干。
IL-6 is a potent inducer of the acute phase response and is produced by T cells, macrophages, fibroblasts, endothelial, and other cells (1,2). IL-6 induces proliferation and differentiation and acts on B cells, T cells, thymocytes, among others. IL-6 in concert with TGF-β is important for developing Th17 responses. IL-6 binds to IL-6Rα and through this association induces gp130 homodimerization (1). gp130 homodimerization triggers the Jak/Stat cascade and the SHP2/MAPK (Erk) cascade (1,3,4). IL-6 also forms a complex with an IL-6Rα splice variant that is non-membrane associated (3). This IL-6/soluble IL-6Rα complex can activate the gp130 signaling pathway on cells that express gp130, but not IL-6Rα (3). Research studies have shown that IL-6 may contribute to metastatic breast cancer by increasing expression of proangiogenic VEGF (5).
IL-6是一个潜在的急性期应答的诱导因子，它由T细胞、巨噬细胞、纤维原细胞、内皮细胞和其它细胞产生(1,2)。IL-6诱导细胞增殖和分化并作用于B细胞、T细胞、胸腺细胞和其它细胞之中。IL-6与TGF-β相作用，对Th17应答的发展非常重要。IL-6与IL-6Rα结合并通过此结合诱导gp130的同型二聚化(1)。gp130的同型二聚化引起Jak/Stat级联反应和SHP2/MAPK (Erk)级联反应(1,3,4)。IL-6也能与IL-6Rα可变剪切形成与膜无关的复合体(3)。IL-6/可溶性 IL-6Rα 复合体在表达gp130的细胞上能激活gp130信号通路,但不是IL-6Rα (3)。一些研究证明IL-6可能通过增加促血管新生因子 VEGF对乳腺癌的转移有作用(5)。
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
- 4904 Stat3 (79D7) Rabbit mAb
- 7300 PathScan® Phospho-Stat3 (Tyr705) Sandwich ELISA Kit
- 9145 Phospho-Stat3 (Tyr705) (D3A7) XP® Rabbit mAb
- 9872 Phosphate Buffered Saline (PBS-1X) pH7.2 (Sterile)
For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
PathScan is a trademark of Cell Signaling Technology, Inc.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.
用户评论 --- 共 0 条